- Hikma Pharmaceuticals
- 17 September 2025 14:47:59
Source: Sharecast
Hikma said executive vice chairman Mazen Darwazah purchased 14,000 shares in the company at a price of 1,603p each, for a total consideration of about £224,418.
The transaction took place on 16 September on the London Stock Exchange.
Separately, Kier said two senior executives sold a combined 600,000 shares the same day.
Chief financial officer Simon Kesterton disposed of 350,000 shares at 203.95p apiece, raising around £713,825.
Group managing director for transportation Giuseppe Incutti meanwhile sold 125,000 shares at 209.51p, 67,500 at 202.79p, and 57,500 at 205.01p, for a total of approximately £516,653.
At 1429 BST, shares in Hikma Pharmaceuticals were up 0.37% at 1,622p, while those in Kier Group were ahead 1.46% at 208.5p.
Reporting by Josh White for Sharecast.com.
Top Director Buys
Hikma Pharmaceuticals (HIK)
Director name: Darwazah,Mazen
Amount purchased: 14,000 @ 1,603.00p
Value: £224,420.01
Empire Metals Limited Npv (di) (EEE)
Director name: Bunn,Shaun
Amount purchased: 40,000 @ 36.50p
Value: £14,600.00
Sthree (STEM)
Director name: Lehne,Timo
Amount purchased: 7,404 @ 139.00p
Value: £10,291.56
Eden Research (EDEN)
Director name: M. Smith,Sean
Amount purchased: 390,624 @ 2.56p
Value: £9,999.97
Eden Research (EDEN)
Director name: Abrey,Alexander John
Amount purchased: 360,490 @ 2.77p
Value: £9,985.57
Revolution Beauty Group (REVB)
Director name: McDonald,Iain
Amount purchased: 333,334 @ 2.95p
Value: £9,833.35
Top Director Sells
Kier Group (KIE)
Director name: Kesterton,Simon
Amount sold: 350,000 @ 203.95p
Value: £713,825.00
Bango (BGO)
Director name: Anderson, Ray
Amount sold: 32,500 @ 101.30p
Value: £32,922.50
Staffline Group (STAF)
Director name: Spain,Thomas
Amount sold: 10,357 @ 40.60p
Value: £4,204.94